Inhibition of inflammatory cytokine production and protection against endotoxin toxicity by benzydamine

Cytokine

Volumn 8, Issue 9, 1996, Pages 710-716

  Sironi, M ^a   Pozzi, P ^a   Polentarutti, N ^a   Benigni, F ^a   Coletta, I ^b   Guglielmotti, A ^a   Milanese, C ^b   Ghezzi, P ^a   Vecchi, A ^a   Pinza, M ^b   Mantovani, A ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b Università Politecnica delle Marche ACRAF Gruppo Angelini   (Italy)

Author keywords

Anti inflammatory drug; Endotoxin toxicity inflammatory cytokines; TNF

Indexed keywords

ANTIINFLAMMATORY AGENT; BENZYDAMINE; CYTOKINE; ENDOTOXIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; MORTALITY; MOUSE; NONHUMAN; NORMAL HUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPTIC SHOCK; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA;

EID: 0030249568     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0094     Document Type: Article

References (19)

1. 1. Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K, Shahinian A, Wiegmann K, Ohashi PS, Kronke M, Mak TW (1993) Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457-467.
2. 2. Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, Althage A, Zinkernagel R, Steinmetz M, Bluethmann H (1993) Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798-802.
3. 3. Beutler B, Milsark IW, Cerami AC (1985) Passive immunization against cachectin/Tumor Necrosis Factor protects mice from lethal effect of endotoxin. Science 229:869-871.
4. 4. Ohlsson K, Bjork P, Bergenfeldt M, Hageman R, Thompson RC (1990) Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 348:550-552.
5. 5. Gadina M, Bertini R, Mengozzi M, Zandalasini M, Mantovani A, Ghezzi P (1991) Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock. J Exp Med 173:1305-1310.
6. 6. Mengozzi M, Fantuzzi G, Faggioni R, Marchant A, Goldman M, Orencole S, Clark BD, Sironi M, Benigni F, Ghezzi P (1994) Chlorpromazine specifically inhibits peripheral and brain TNF production, and up-regulates IL-10 production, in mice. Immunology 82:207-210.
7. 7. Noel P, Nelson S, Bokulic R, Bagby G, Lippton H, Lipscomb G, Summer W (1990) Pentoxifylline inhibits lipopolysaccharide-induced serum tumor necrosis factor and mortality. Life Sci 47:1023-1029.
8. 8. Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G (1993) Thalidomide exerts its inhibitory action on tumor necrosis factor α by enhancing mRNA degradation. J Exp Med 177:1675-1680.
9. 9. Novogrodsky A, Vanichkin A, Patya M, Gazit A, Osherov N, Levitzki A (1994) Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science 264:1319-1322.
10. 10. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, Strickler JE, McLaughlin MM, Siemens IR, Fisher SM, Livi GP, White JR, Adams JL, Young PR (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739-746.
11. 11. Mohler KM, Sleath PR, Fitzner JN, Cerretti DP, Alderson M, Kerwar SS, Torrance DS, Otten Evans C, Greenstreet T, Weerawarna K, Kronheim SR, Petersen M, Gerhart M, Kozlosky CJ, March CJ, Black RA (1994) Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature 370:218-220.
12. 12. Cioli V, Corradino C, Scorza Barcellona P (1985) Review of pharmacological data on Benzidamine. Int J Tiss Reac VII:205-213.
13. 13. Semmler J, Gebert U, Eisenhut T, Moeller J, Schonharting MM, Allera A, Endres S (1993) Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity. Immunology 78:520-525.
14. 14. Young P, McDonnell P, Dunnington D, Hand A, Laydon J, Lee J (1993) Pyridinyl imidazoles inhibit IL-1 and TNF production at the protein level. Agents Actions 39:C67-C69.
15. 15. Proctor RA, Denlinger LC, Leventhal PS, Daugherty SK, van de Loo JW, Tanke T, Firestein GS, Bertics PJ (1994) Protection of mice from endotoxic death by 2-methylthio-ATP. Proc Natl Acad Sci USA 91:6017-6020.
16. 16. Schade UF, Engel R, Jakobs D (1991) Differential protective activities of site specific lipoxygenase inhibitors in endotoxic shock and production of tumor necrosis factor. Int J Immunopharmacol 13:565-571.
17. 17. Kankova M, Luini W, Pedrazzoni M, Riganti F, Sironi M, Bottazzi B, Mantovani A, Vecchi A (1991) Impairment of cytokine production in mice fed a vitamin D3-deficient diet. Immunology 73:466-471.
18. 18. Sironi M, Breviario F, Proserpio P, Biondi A, Vecchi A, Van Damme J, Dejana E, Mantovani A (1989) IL-1 stimulates IL-6 production in endothelial cells. J Immunol 142:549-553.
19. 19. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ (1979) Isolation of a biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5300.